Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)

George Lau; Ming Lung Yu; Grace Wong; Alexander Thompson; Hasmik Ghazinian; Jin Lin Hou; Teerha Piratvisuth; Ji Dong Jia; Masashi Mizokami; Gregory Cheng; Guo Feng Chen; Zhen Wen Liu; Oidov Baatarkhuu; Ann Lii Cheng; Woon Leung Ng; Patrick Lau; Tony Mok; Jer Ming Chang; Saeed Hamid; A. Kadir Dokmeci; Rino A. Gani; Diana A. Payawal; Pierce Chow; Joong Won Park; Simone I. Strasser; Rosmawaiti Mohamed; Khin Maung Win; Tawesak Tanwandee; Shiv Kumar Sarin; Masao Omata

ArticleOPEN ACCESS

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)

Hepatology International

DOI: 10.1007/s12072-022-10301-2

3Citations

7Readers

Get full text

Abstract

Unfortunately, the first and last name of the Co-author, Tawesak Tanwandee has been interchanged in the original publication of the article. The correct first name should read as “Tawesak” and the last name should read as “Tanwandee” respectively.

Cite

CITATION STYLE

APA

Lau, G., Yu, M. L., Wong, G., Thompson, A., Ghazinian, H., Hou, J. L., … Omata, M. (2022, April 1). Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x). Hepatology International. Springer. https://doi.org/10.1007/s12072-022-10301-2

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)

Abstract

Cite

Register to see more suggestions